MINNEAPOLIS, Sept. 11, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that Dr. Amelia Warner of Clinical Trial Concepts has been appointed as the newest member of its Scientific Advisory Board. Amelia Wall Warner, PharmD, RPh, is the Founder and CEO of Clinical Trial Concepts. She was previously the CEO and founder of the successful Global Specimen Solutions, Inc.Read more
- Medical Marijuana, Inc. Subsidiaries Kannaway®, HempMeds® and Dixie Botanicals Receive U.S. Hemp Authority Certification Seal
- Midwest Energy Emissions Corp. Secures Multi-Year Contract Renewal of $1M per Year
- INVO BIOSCIENCE LAUNCHES EMBRYOLOGY CENTER IN THE BAY AREA TO SUPPORT DEDICATED INVOCELL CLINIC BEING DEVELOPED BY DR. AIMEE, THE “EGG WHISPERER”
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More